Sunday, Jan 30, 2005
Sunday, Jan 30, 2005 |
| New Delhi | ||||
|
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts: Classifieds | Employment | Obituary | New Delhi
By Our Staff Reporter
NEW DELHI, JAN. 29. The shift from illness to wellness and the quest for excellence will be the highlight of the 33rd National Conference of Indian Association of Dermatologist, Venereologists and Leprologists and the 4th South Asian Regional Conference of Dermatology, Venerology and Leprology, beginning in the Capital on February 3. Almost 4,500 delegates from India and abroad including over 300 attendees from SAARC countries are expected to participate in the four-day conference. Also, guest faculty from as many as 15 countries will present more than 800 scientific papers here. Elaborating on the focus of the conference, the organising general secretary, Vijay K.Garg, said: "The field of dermatology is breaking its shackles and finally coming of age in India too. From just administering treatment for common problems like psoriasis, hair and nail problems, we are moving on to the advent and public acceptance of emerging fields of cosmetology and advanced dermatological surgeries. These include various advanced techniques.'' Speaking about leprosy and its eradication, the organising member, R.P. Gupta, said: "We have to understand that although multi-drug therapy for leprosy has reduced the numbers, we can't sit back and relax. According to the 2002 report of the International Leprosy Association Technical Forum, new cases detection rates/incidence rates have more or less remained constant over the last decade. These factors require us to take a closer look at the existing World Health Organisation drug regime so as to improve further to make a more comprehensive and effective change. One ray of hope though is the major technological advance in identifying highly effective drugs. Similarly, gene probes and gene amplification systems have been developed to monitor treatment. The focus now is also shifting to immuno-therapeutic vaccines that may be employed as an addition to chemotherapy in future. With all these advances, the control of leprosy can be achieved in the near future.''
Printer friendly
page
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
|
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu
|
